The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation.

Showing 10 Results

E.V.I.dently® | August 2022

In this issue: Evidence and drug pricing policy, wages and access to care, the (minimal) costs of expanding pre-deductible coverage.

E.V.I.dently® | May 2022

In this issue: Improving benefit design, patient perspectives on innovation, resources to guide health spending research and policy-making & more.

E.V.I.dently® | March 2022

In this issue: Measuring the impact of innovation, new resources to navigate health spending research and policy-making, good practices for HDHPs and a busy spring event calendar.

E.V.I.dently® | January 2022

In this issue: We offer a new resource on the myth of the "average" patient, outline key challenges in value assessment and health technology assessment, and highlight two upcoming webinars.

E.V.I.dently® | November 2021

In this issue: Explore the pitfalls in the most recent drug pricing deal, regulation that's led to improvements in employee benefits and keys to improving equity in health coverage. 

E.V.I.dently® | September 2021

In this issue: Explore drug pricing and innovation, patient input in health benefit design, the research infrastructure to examine social determinants of health and upcoming events.

E.V.I.dently® - July 2021

In this issue: meet NPC's new president and CEO, learn how we can tackle low-value care, what we need to know about the budget cap dilemma, and catch up on news you might have missed!